Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial

Fig. 3

Between-group time course of circulating hematological and inflammatory markers of severity. Circulating lymphocyte (a), neutrophil (b), monocyte (c), CXCL-10 (d), IL-6 (e), TNF (f), and IFN-γ (g) values. Sample sizes at each time point are indicated. All data are shown as median ± IQR. Only the upper quartile for the group with the highest value and the lower quartile for the group with the smallest value are shown to avoid image cluttering

Back to article page

Molecular Medicine

ISSN: 1528-3658